Overman, M. J., LoRusso, P., Strickler, J. H., Patel, S. P., Clarke, S. J., Noonan, A. M., … Bendell, J. C. (2018). Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc). In Journal of Clinical Oncology (Vol. 36, pp. 4123–4123). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.4123

Overman, Michael J., Patricia LoRusso, John H. Strickler, Sandip Pravin Patel, Stephen John Clarke, Anne M. Noonan, Thiru Prasanna, et al. “Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).” In Journal of Clinical Oncology, 36:4123–4123. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.4123.

Overman MJ, LoRusso P, Strickler JH, Patel SP, Clarke SJ, Noonan AM, et al. Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 4123–4123.

Overman, Michael J., et al. “Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc).” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 4123–4123. Crossref, doi:10.1200/jco.2018.36.15_suppl.4123.

Overman MJ, LoRusso P, Strickler JH, Patel SP, Clarke SJ, Noonan AM, Prasanna T, Amin MA, Nemunaitis JJ, Desai J, O’Byrne KJ, George TJ, Englert J, She D, Cooper ZA, Wu Y, Khan A, Kumar R, Bendell JC. Safety, efficacy and pharmacodynamics (PD) of MEDI9447 (oleclumab) alone or in combination with durvalumab in advanced colorectal cancer (CRC) or pancreatic cancer (panc). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 4123–4123.